lipodystrophy: a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Greek for "fat", and "dystrophy" is Greek for "abnormal or degenerative condition".)
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
54 |
4. Check minimum number of eventsNone |
54 |
5. Include endpointsNone |
54 |
6. Filter based on genotype QC (FinnGen only) |
54 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E88
- Name in latin
- Lipodystrophia non alibi classificata
Similar endpoints
↥List of similar endpoints to
Lipodystrophy, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other metabolic disorders
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 334 | 268 | 64 |
| Only index persons | 300 | 253 | 47 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 43.45 | 43.19 | 44.22 |
| Only index persons | 43.54 | 42.71 | 48.02 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 54 | 43 | 11 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 50.48 | 49.01 | 56.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022313) Gas panel - Capillary blood
7
13
6.00
2.97
1.7
1.9
—
—
—
0
0
(4306422)
5
6
9.01
2.80
1.4
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
23
123
2.52
2.65
4.9
2.8
mg/l
16.7
18.1
0.05
12
78
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
21
4.28
2.58
4.6
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
8
6.74
2.42
1.4
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
10
5.38
2.12
3.0
1.9
%
151.8
146.2
—
5
10
(3037467) Urinalysis macro (dipstick) panel - Urine
43
328
2.53
2.01
7.7
3.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
5
133
0.31
1.98
11.0
3.7
—
0.0
—
0
44
(3020682) Albumin/Creatinine [Ratio] in Urine
22
131
2.15
1.88
5.6
3.4
mg/mmol
2.6
2.4
0.05
11
76
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
12
4.47
1.86
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
42
2.69
1.80
3.9
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
30
206
2.03
1.72
7.3
4.5
mmol/l
1.2
1.2
0.00
25
173
(40761536) Microorganisms panel - Urine sediment
0
44
0.00
1.60
0.0
3.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
0
44
0.00
1.60
0.0
3.8
—
1.2
—
0
36
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
16
3.33
1.47
1.8
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
29
2.62
1.44
4.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
17
3.13
1.39
1.8
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
24
165
1.82
1.28
2.3
2.0
pmol/l
104.6
96.3
0.43
14
90
(3012544) pH of Venous blood
8
38
2.29
1.25
2.5
3.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
26
186
1.77
1.20
7.7
4.2
mmol/l
1.2
1.2
0.17
21
166
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
27
196
1.76
1.18
4.0
2.1
nmol/l
76.8
77.1
0.02
21
171
(40760892) CBC W Ordered Manual Differential panel - Blood
5
107
0.41
1.17
14.0
6.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
0
32
0.00
0.98
0.0
7.8
—
0.2
—
0
5
(3018418) pH of Serum or Plasma
19
131
1.69
0.96
3.4
3.6
—
7.4
—
0
25
(36660697) Celiac disease serology panel - Serum
8
42
2.06
0.94
1.4
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
30
2.12
0.90
14.5
4.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
23
2.29
0.78
2.6
4.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
46
413
1.77
0.76
8.3
5.0
mmol/mol
40.8
38.7
0.67
41
376
(3044889) 12 lead EKG panel
28
336
0.65
0.75
4.4
3.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
42
1.76
0.71
2.9
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
42
1.76
0.71
2.9
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
42
1.76
0.71
1.1
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
27
1.94
0.70
1.2
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
27
1.94
0.70
1.2
2.1
g/l
126.2
135.0
—
5
27
(3022217) INR in Platelet poor plasma by Coagulation assay
7
43
1.72
0.70
37.9
11.0
—
1.4
—
0
7
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
44
1.68
0.68
2.0
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
8
49
1.74
0.66
3.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11
158
0.62
0.65
2.5
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
190
0.64
0.65
6.6
3.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
64
1.69
0.64
2.4
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
20
0.00
0.62
0.0
1.6
—
1230.1
—
0
9
(3027801) Oxygen [Partial pressure] in Arterial blood
6
36
1.75
0.59
14.3
4.7
kpa
13.0
11.7
—
6
36
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
6
36
1.75
0.59
14.3
4.7
kpa
5.0
4.9
—
6
36
(3019225) pH of Specimen
6
37
1.70
0.58
2.7
2.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
14
101
1.52
0.57
1.7
1.3
g/l
2.0
2.3
—
8
55
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
34
293
1.43
0.55
2.6
3.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
25
204
1.42
0.55
3.8
3.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
21
166
1.43
0.55
2.6
2.9
ng/l
14.2
26.9
1.85
14
110
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
12
84
1.55
0.55
2.2
1.8
mg/l
0.5
0.9
—
7
64
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
64
1.49
0.55
1.7
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
19
149
1.42
0.51
10.9
5.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
49
459
1.73
0.50
16.5
11.0
mg/l
21.0
19.9
0.10
38
338
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
7
47
1.56
0.50
1.7
2.8
u/l
26.6
29.7
—
7
37
(3023368) Bacteria identified in Blood by Culture
13
95
1.49
0.49
2.8
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
47
439
1.54
0.45
16.7
10.6
ml/min/173m2
81.0
82.7
0.20
35
356
(3002173) Hemoglobin [Mass/volume] in Arterial blood
5
31
1.67
0.44
16.0
5.0
g/l
116.4
121.3
—
5
31
(3022621) pH of Urine by Test strip
5
31
1.67
0.44
7.4
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
8
58
1.44
0.44
1.9
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
5
32
1.62
0.43
16.6
4.8
%
97.1
96.1
—
5
32
(3041096) Erythrocytes [Presence] in Urine by Automated
10
134
0.69
0.41
7.6
2.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
6
43
1.44
0.36
21.2
4.4
mmol/l
107.3
104.2
—
6
43
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
48
452
1.56
0.36
5.6
4.6
mu/l
1.9
1.9
0.04
42
405
(3042936) Bacteria identified in Isolate by Culture
7
51
1.43
0.33
2.7
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
46
435
1.39
0.33
21.7
11.6
%
38.8
40.2
0.43
31
317
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
113
1.32
0.30
1.7
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
18
151
1.29
0.30
5.2
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
8
61
1.36
0.30
15.8
2.6
mmol/l
0.8
0.8
—
8
53
(3009261) Glucose [Presence] in Urine by Test strip
21
238
0.81
0.25
6.6
3.4
—
0.0
—
0
45
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12
97
1.30
0.25
2.0
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
21
236
0.82
0.23
10.2
4.5
—
0.0
—
0
42
(3044640) Blood type and Crossmatch panel - Blood
15
127
1.25
0.23
2.1
2.1
—
—
—
0
0
(4035726)
5
42
1.21
0.22
1.4
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4281824)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
3.2
—
84.6
—
0
10
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
4.0
—
0
5
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
0
12
0.00
0.21
0.0
4.9
—
1.5
—
0
12
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
13
0.00
0.21
0.0
4.6
—
1.0
—
0
13
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(4034850)
0
14
0.00
0.20
0.0
7.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
60
1.19
0.19
2.7
7.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
15
130
1.21
0.18
1.4
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
15
130
1.21
0.18
2.9
1.8
u/l
123.4
119.2
0.08
15
120
(3013512) EKG study
14
122
1.20
0.16
5.1
3.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
36
377
0.86
0.13
4.5
3.9
pmol/l
15.1
14.7
0.41
31
335
(36304419) Bacteria [Presence] in Urine
14
124
1.17
0.13
4.6
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
12
105
1.18
0.12
4.9
3.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
86
1.20
0.12
1.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
46
1.10
0.10
1.2
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
5
47
1.07
0.10
3.0
2.5
umol/l
6.5
10.5
—
5
40
(3002256) Pathology report gross observation
5
62
0.79
0.09
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
22
234
0.90
0.08
6.3
3.4
—
0.0
—
0
45
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
8
75
1.08
0.08
6.4
4.7
ug/l
1.8
1.8
—
8
64
(40768804) Tissue Pathology biopsy report
21
197
1.11
0.08
3.3
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
47
459
1.18
0.07
6.9
4.8
mmol/l
2.5
2.8
1.67
42
412
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
82
1.12
0.07
2.0
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
39
402
0.89
0.07
23.3
13.4
%
13.2
13.7
2.01
39
394
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
46
447
1.20
0.07
5.3
4.5
mmol/l
6.0
5.8
0.43
41
403
(3000850) Epithelial cells [#/volume] in Urine
8
93
0.84
0.07
5.4
2.5
e6/l
8.8
5.2
—
8
81
(3026493) Urate [Moles/volume] in Serum or Plasma
9
103
0.85
0.07
7.7
2.6
umol/l
41810.2
11551.0
—
9
87
(3026008) Bacteria identified in Urine by Culture
15
139
1.11
0.06
4.0
2.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
12
112
1.09
0.03
10.3
6.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
14
141
0.99
0.00
6.0
2.3
u/l
55.3
52.9
0.18
14
127
(3018572) Chloride [Moles/volume] in Blood
0
8
0.00
0.00
0.0
6.6
—
107.3
—
0
8
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
7
0.00
0.00
0.0
1.0
—
22.2
—
0
7
(3023511) Choriogonadotropin [Units/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
7
0.00
0.00
0.0
8.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3039000) Anion gap in Blood
0
8
0.00
0.00
0.0
6.6
—
10.0
—
0
8
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
3.3
—
0
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
34.2
—
0
5
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
9
0.00
0.00
0.0
2.0
—
4.0
—
0
9
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.8
—
34.3
—
0
5
(3036782) Glucose [Moles/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.5
—
6.5
—
0
6
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
8
86
0.92
0.00
1.6
2.3
mmol/l
2.4
2.5
—
8
77
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
2.6
—
32.4
—
0
5
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
2.1
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
2.0
—
14.5
—
0
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
9
0.00
0.00
0.0
3.7
—
60.9
—
0
9
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
49
489
1.02
0.00
21.8
13.1
umol/l
75.1
72.1
0.47
49
489
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
89.7
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.4
—
144.7
—
0
5
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_LIPODYST and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have E4_LIPODYST.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: E4_LIPODYST – Lipodystrophy, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data